Leech powder on oral acute cerebral hemorrhage on prognosis of early and mid.docVIP

 PAGE \* MERGEFORMAT 13 Leech powder on oral acute cerebral hemorrhage on prognosis of early and mid Of: Wang Daming, Huhao Yu, Zheng as red, Hu Yana [Abstract] Objective To investigate oral powder leech on acute cerebral hemorrhage early impact of clinical outcomes. Methods 59 cases of cerebral hemorrhage in patients with case-control study of the treatment group and no differences between treatment groups and the influence on prognosis. The results are about 2 / 3 of the patients after oral treatment leech powder, the average dose (2.22 + -0.42) g / d, mean duration of treatment (10.12 + -3.39) d. discharge in patients treated with Glasgow scores higher than the untreated group (P = 0.001), early modified Rankin 5 to 6 points 43.9% (61.1% in untreated group, P = 0.45), mortality rate 2.4% (no treatment group 16.7%, P = 0.08), mid-term modified Rankin 5 to 6 points 17.1% (no treatment group 50%, P = 0.03), mortality rate 17.1% (not treatment group, 44.4%, P = 0.03). Correction Glasgow score at admission, blood glucose, creatinine, and smoking history and other factors, Logistic regression analysis showed that medium-term prognosis led to differences between the 2 groups because of leech therapy has played a certain role. Conclusion Hirudo powder oral treatment of acute cerebral hemorrhage, especially in the efficacy of early clinical outcomes is uncertain, still need a larger sample through the evaluation of randomized controlled trials. [Keywords:] Leech, cerebral hemorrhage, prognosis, mortality, disability rates Abstract: Objective To study the effect of leech powder on mortality and disability of acute intracerebral hemorrhage at 30 days and 1 year. Methods In a Case-control study, we analyzed the 30-day and 1-year mortality and disability with respect to leech powder treatment status in 59 patients consecutively admitted within one week of intracerebral hemorrhage onset. Confounding factors were compared between treated and nontreated patient